PGENYPGENYOTC
Loading
EBITDA Over TimeContracting
Percentile Rank21
3Y CAGR-6.6%
5Y CAGR-6.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-6.6%/yr
vs -7.2%/yr prior
5Y CAGR
-6.2%/yr
Consistent
Acceleration
+0.6pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$13.97B-21.6%
2024$17.82B+9.1%
2023$16.33B-4.7%
2022$17.14B-2.0%
2021$17.50B-9.3%
2020$19.29B-12.7%
2019$22.10B-4.2%
2018$23.07B+5.5%
2017$21.86B+19.0%
2016$18.37B-